Grabner, Alexander http://orcid.org/0000-0002-5544-1896
Schramm, Karla
Silswal, Neerupma
Hendrix, Matt
Yanucil, Christopher
Czaya, Brian
Singh, Saurav
Wolf, Myles http://orcid.org/0000-0002-1127-1442
Hermann, Sven
Stypmann, Jörg
Di Marco, Giovana Seno
Brand, Marcus
Wacker, Michael J.
Faul, Christian
Article History
Received: 1 March 2017
Accepted: 12 April 2017
First Online: 16 May 2017
Competing Interests
: C.F. has served as a consultant or received honoraria from Ultragenyx and has received research support from U3 Pharma GmbH and Roche. M.W. has served as a consultant or received honoraria from Ultragenyx, Amgen, Keryx, Lutipold, Pfizer and Sanofi. All other authors have declared that no conflict of interest exists.